Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Central Sleep Apnea Patients Undergoing remedē System Implant

NCT07907068 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07907068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Central Sleep Apnea Patients Undergoing remedē System Implant
Lead sponsor
Zoll Medical Corporation
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2027
Completion date
May 31, 2037
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, central sleep apnea (diagnosis), central sleep apnea syndrome, sleep apnea, central

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of serious adverse events (SAEs) related to the remedē System implant procedure, device, or delivered therapy through 12 months post implant From implant to 12 months post implant

Lead sponsor's other trials

Zoll Medical Corporation, most recent start first.

Similar trials

Same condition (Sleep Apnea, Central) and phase, most recent start first.